We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.34B
AUM Growth
–
Cap. Flow
+$5.62B
Cap. Flow %
105.35%
Top 10 Hldgs %
16.76%
Holding
517
New
456
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$173M
2
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
+$92.2M
3
MDLZ icon
Mondelez International
MDLZ
+$78.2M
4
EL icon
Estee Lauder
EL
+$66.3M
5
KO icon
Coca-Cola
KO
+$65.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.12%
2 Real Estate 12.96%
3 Consumer Discretionary 7.68%
4 Healthcare 7.54%
5 Financials 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IYR icon
326
PUT
iShares US Real Estate ETF
IYR
$4.63B
$858K 0.02%
+100,000
New +$7.07M
NOC icon
327
Northrop Grumman
NOC
$80.7B
$828K 0.02%
+10,000
New +$778K
CEMP
328
DELISTED
Cempra, Inc.
CEMP
$783K 0.01%
+100,000
New +$691K
SLCA
329
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$773K 0.01%
+37,187
New +$797K
ASTX
330
DELISTED
ASTEX PHARMACEUTICALS, INC COM
ASTX
$773K 0.01%
+188,000
New +$1.01M
SGYP
331
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$756K 0.01%
+177,450
New +$892K
HTLD icon
332
Heartland Express
HTLD
$952M
$729K 0.01%
+52,530
New +$724K
TT icon
333
Trane Technologies
TT
$105B
$720K 0.01%
+16,240
New +$722K
DNDN
334
DELISTED
DENDREON CORPORATION
DNDN
$692K 0.01%
+168,000
New +$715K
NBR icon
335
Nabors Industries
NBR
$1.23B
$688K 0.01%
+899
New +$712K
WCC
336
WESCO International
WCC
$18.1B
$681K 0.01%
+10,027
New +$715K
BIOA
337
DELISTED
BioAmber Inc.
BIOA
$680K 0.01%
+100,000
New +$744K
FCX icon
338
Freeport-McMoran
FCX
$95.5B
$622K 0.01%
+22,528
New +$688K
MITK icon
339
Mitek Systems
MITK
$759M
$604K 0.01%
+104,584
New +$562K
CIE
340
DELISTED
Cobalt International Energy, Inc
CIE
$604K 0.01%
+1,516
New +$614K
ONCY
341
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
$576K 0.01%
+200,000
New +$553K
GOOD
342
Gladstone Commercial Corp
GOOD
$625M
$559K 0.01%
+30,000
New +$587K
CLX icon
343
PUT
Clorox
CLX
$12.8B
$545K 0.01%
+300,000
New +$25.8M
MERU
344
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
$544K 0.01%
+135,000
New +$661K
PPLT
345
abrdn Physical Platinum Shares ETF
PPLT
$1.99B
$524K 0.01%
+40,000
New +$575K
FITB
346
Fifth Third Bancorp
FITB
$51.7B
$501K 0.01%
+27,769
New +$484K
GS icon
347
PUT
Goldman Sachs
GS
$301B
$500K 0.01%
+71,200
New +$10.9M
ECYT
348
DELISTED
Endocyte, Inc. Common Stock
ECYT
$499K 0.01%
+38,000
New +$512K
DEI icon
349
Douglas Emmett
DEI
$1.93B
$473K 0.01%
+18,961
New +$489K
ANF icon
350
Abercrombie & Fitch
ANF
$4.91B
$472K 0.01%
+10,429
New +$514K
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for UBS O'Connor, which disclosed 517 positions worth $5.34B. Its ten largest holdings account for 17% of the portfolio.

Its largest position is Pfizer: 6,269,077 shares worth $167M.

By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, followed by Real Estate and Consumer Discretionary.

  • UBS O'Connor's largest Q2 2013 buy was Pfizer: 6,269,077 shares worth $167M.
  • UBS O'Connor's ten largest holdings make up 17% of its $5.34B portfolio in Q2 2013.
  • UBS O'Connor disclosed 517 positions in Q2 2013, its first 13F filing on record.

Based on UBS O'Connor's 13F filing for Q2 2013, filed 13 Aug 2013.